Evidence map›Paper›PMID 38745894›Full record

ArticleMolecular therapy. Methods & clinical development2024

Rescue of myocytes and locomotion through

Gabriella Fernandes-Pires, Marcelo Duarte Azevedo, Marc Lanzillo, Clothilde Roux-Petronelli, Pierre-Alain Binz, Cristina Cudalbu, Carmen Sandi, Liliane Tenenbaum, Olivier Braissant

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. [Scientific reports · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gabriella Fernandes-PiresService of Clinical Chemistry, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Marcelo Duarte AzevedoLaboratory of Cellular and Molecular Neurotherapies, Clinical Neurosciences Department, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Marc LanzilloService of Clinical Chemistry, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Clothilde Roux-PetronelliService of Clinical Chemistry, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Pierre-Alain BinzService of Clinical Chemistry, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Cristina CudalbuCentre d'Imagerie Biomedicale (CIBM), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Carmen SandiBrain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Liliane TenenbaumLaboratory of Cellular and Molecular Neurotherapies, Clinical Neurosciences Department, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.
Olivier BraissantService of Clinical Chemistry, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creatine deficiency syndromes (CDS), caused by mutations in

Indexed as

adeno-associated virusbraincreatine transporter deficiencygene therapylocomotionmuscleSLC6A8

Identifiers

PMID38745894
PMCPMC11091509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.